JP2004536046A5 - - Google Patents

Download PDF

Info

Publication number
JP2004536046A5
JP2004536046A5 JP2002578971A JP2002578971A JP2004536046A5 JP 2004536046 A5 JP2004536046 A5 JP 2004536046A5 JP 2002578971 A JP2002578971 A JP 2002578971A JP 2002578971 A JP2002578971 A JP 2002578971A JP 2004536046 A5 JP2004536046 A5 JP 2004536046A5
Authority
JP
Japan
Prior art keywords
acne
pharmaceutical composition
tetracycline
administered
composition according
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2002578971A
Other languages
English (en)
Japanese (ja)
Other versions
JP2004536046A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2002/010747 external-priority patent/WO2002080932A1/en
Publication of JP2004536046A publication Critical patent/JP2004536046A/ja
Publication of JP2004536046A5 publication Critical patent/JP2004536046A5/ja
Pending legal-status Critical Current

Links

JP2002578971A 2001-04-05 2002-04-05 ざ瘡の治療方法 Pending JP2004536046A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US28191601P 2001-04-05 2001-04-05
PCT/US2002/010747 WO2002080932A1 (en) 2001-04-05 2002-04-05 Methods of treating acne

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2009280436A Division JP2010053155A (ja) 2001-04-05 2009-12-10 ざ瘡の治療方法

Publications (2)

Publication Number Publication Date
JP2004536046A JP2004536046A (ja) 2004-12-02
JP2004536046A5 true JP2004536046A5 (enExample) 2005-12-22

Family

ID=23079310

Family Applications (3)

Application Number Title Priority Date Filing Date
JP2002578971A Pending JP2004536046A (ja) 2001-04-05 2002-04-05 ざ瘡の治療方法
JP2009280436A Pending JP2010053155A (ja) 2001-04-05 2009-12-10 ざ瘡の治療方法
JP2011115785A Pending JP2011168613A (ja) 2001-04-05 2011-05-24 ざ瘡の治療方法

Family Applications After (2)

Application Number Title Priority Date Filing Date
JP2009280436A Pending JP2010053155A (ja) 2001-04-05 2009-12-10 ざ瘡の治療方法
JP2011115785A Pending JP2011168613A (ja) 2001-04-05 2011-05-24 ざ瘡の治療方法

Country Status (12)

Country Link
EP (4) EP1716856A3 (enExample)
JP (3) JP2004536046A (enExample)
KR (1) KR100926326B1 (enExample)
AT (1) ATE330615T1 (enExample)
AU (1) AU2002303250B2 (enExample)
CA (2) CA2719162C (enExample)
DE (1) DE60212613T2 (enExample)
DK (1) DK1383508T3 (enExample)
ES (1) ES2266499T3 (enExample)
NZ (1) NZ528197A (enExample)
PT (1) PT1383508E (enExample)
WO (1) WO2002080932A1 (enExample)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2311797A1 (en) * 2002-01-08 2011-04-20 Paratek Pharmaceuticals, Inc. 4-dedimethylamino tetracycline compounds
US8192749B2 (en) 2003-04-16 2012-06-05 Galderma Laboratories Inc. Methods of simultaneously treating ocular rosacea and acne rosacea
WO2003088906A2 (en) * 2002-04-16 2003-10-30 Collagenex Pharmaceuticals, Inc. Methods of simultaneously treating ocular rosacea and acne rosacea
CA2521885C (en) 2003-04-07 2013-06-25 Shire Laboratories, Inc. Once daily formulations of tetracyclines
NZ544826A (en) 2003-07-25 2008-07-31 Warner Chilcott Co Inc A doxycycline metal complex in a solid dosage form
EP1684768A4 (en) * 2003-11-06 2007-06-06 Univ New York State Res Found METHOD FOR TREATING ECCEM
US9192615B2 (en) 2008-08-06 2015-11-24 Medicis Pharmaceutical Corporation Method for the treatment of acne and certain dosage forms thereof
US7919483B2 (en) * 2005-06-24 2011-04-05 Medicis Pharmaceutical Corporation Method for the treatment of acne
US7544373B2 (en) 2007-04-02 2009-06-09 Medicis Pharmaceutical Corporation Minocycline oral dosage forms for the treatment of acne
US8252776B2 (en) 2007-04-02 2012-08-28 Medicis Pharmaceutical Corporation Minocycline oral dosage forms for the treatment of acne
US7541347B2 (en) 2007-04-02 2009-06-02 Medicis Pharmaceutical Coropration Minocycline oral dosage forms for the treatment of acne
US7704959B2 (en) * 2006-10-03 2010-04-27 Dow Pharmaceutical Sciences Azithromycin for the treatment of nodular acne
JP5395052B2 (ja) * 2007-03-23 2014-01-22 モレキュラー リサーチ センター インコーポレイテッド 炎症を処置するための組成物および方法
WO2008121107A1 (en) * 2007-04-02 2008-10-09 Medicis Pharmaceutical Corporation Minocycline oral dosage forms for the treatment of acne
MX2010012385A (es) * 2008-05-16 2010-12-02 Galderma Res & Dev Regimen de terapia para tratar enfermedades relacionadas al acne.
US9561241B1 (en) 2011-06-28 2017-02-07 Medicis Pharmaceutical Corporation Gastroretentive dosage forms for minocycline
KR20140146095A (ko) * 2012-04-19 2014-12-24 갈데르마 소시에떼아노님 여드름의 치료 방법
RU2557991C1 (ru) * 2014-05-19 2015-07-27 Вячеслав Владимирович Чеботарёв Способ лечения больных вульгарными угрями (акне), страдающих дисплазией соединительной ткани
CO2017001953A1 (es) * 2017-02-27 2018-08-31 Corporacion Univ Lasallista Método de encapsulación de tetraciclinas
CA3070663A1 (en) * 2017-07-21 2019-01-24 Almirall, Llc Treatment of non-inflammatory lesions
MX2020007222A (es) * 2018-01-07 2020-12-10 Dr Reddys Laboratories Ltd Metodos para el tratamiento de afecciones inflamatorias de la piel.
CA3125456A1 (en) * 2019-01-04 2020-07-09 Dermata Therapeutics, Llc Compositions and methods for the treatment of skin conditions
WO2021215405A1 (ja) * 2020-04-20 2021-10-28 国立大学法人大阪大学 免疫賦活化剤、及び治療又は予防用組成物

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1983000628A1 (en) * 1981-08-27 1983-03-03 Bernstein, Joel, E. A method of treating acne vulgaris and composition containing carbamide peroxide
US5122519A (en) * 1989-06-27 1992-06-16 American Cyanamid Company Stable, cosmetically acceptable topical gel formulation and method of treatment for acne
JP3170277B2 (ja) * 1990-08-16 2001-05-28 マーチン,ネイル・エフ 眼瞼炎の局所治療
US5674539A (en) * 1994-12-09 1997-10-07 Tomas; Robert E. Method of treating skin and composition
FR2730930B1 (fr) * 1995-02-27 1997-04-04 Oreal Utilisation d'inhibiteurs de no-synthase pour diminuer l'effet irritant cutane de produits utilises dans le domaine cosmetique ou pharmaceutique
US5827840A (en) * 1996-08-01 1998-10-27 The Research Foundation Of State University Of New York Promotion of wound healing by chemically-modified tetracyclines
US5789395A (en) * 1996-08-30 1998-08-04 The Research Foundation Of State University Of New York Method of using tetracycline compounds for inhibition of endogenous nitric oxide production
US5908838A (en) * 1998-02-19 1999-06-01 Medics Pharmaceutical Corporation Method for the treatment of acne
US6432934B1 (en) * 1998-08-06 2002-08-13 Advanced Vision Research Methods and compositions for topical treatment of eye surface inflammation and related dry eye disease
US6015804A (en) * 1998-09-11 2000-01-18 The Research Foundation Of State University Of New York Method of using tetracycline compounds to enhance interleukin-10 production
EP1124558A4 (en) * 1998-09-28 2004-10-27 Res Foundation Ofstate Univers NEW INHIBITANT AGAINST CATARACT EDUCATION
US5998390A (en) * 1998-09-28 1999-12-07 The Research Foundation Of State University Of New York Combination of bisphosphonate and tetracycline
ES2272097T3 (es) * 1998-11-18 2007-04-16 Collagenex Pharmaceuticals, Inc. Nuevos derivados de 4-desdimetilaminotetraciclina.
JP2001072660A (ja) * 1999-09-08 2001-03-21 Welfide Corp TNF−α産生抑制剤および/またはIL−10産生促進剤

Similar Documents

Publication Publication Date Title
JP2005533766A5 (enExample)
CA2485677A1 (en) Methods of treating allergic reactions
JP2023002662A5 (enExample)
CA2440472A1 (en) Methods of treating acne
JP2010270124A5 (enExample)
RU2010140682A (ru) Способ лечения пациента от инфекции, фармацевтическая композиция (варианты) и лекарственное средство
JP2018520189A5 (enExample)
JPWO2020250915A5 (enExample)
JP2014530842A5 (enExample)
JP2025118775A5 (enExample)
JP2025509278A5 (enExample)
JP2006508128A5 (enExample)
JP2017537067A5 (enExample)
JP2020533402A5 (enExample)
CA2435921A1 (en) Method of cancer therapy
RU2003126176A (ru) Кислотно-аддитивные соли тербинафина и яблочной кислоты
JP2005524622A5 (enExample)
NZ534950A (en) Use of non-antibacterial tetracycline analogs and formulations thereof for the treatment of bacterial exotoxins
CA2489705A1 (en) Use of amide derivative of ge 2270 factor a3 for the treatment of acne
JP2008519848A5 (enExample)
JP2005509663A5 (enExample)
US20050282786A1 (en) Method for reducing c-rective protein levels with non-antibacterial tetracycline formulations
US12109176B1 (en) Effect of glycerol on biofilm forming bacteria and fungi that changes the microbes sensitivity to pro and anti-biofilm non-toxic, non-bonded plasma amino acids and amino acid derivatives
CN111655252A (zh) 含有亚铁氨基酸粒子的组合物及其用于制造治疗或改善胰脏相关疾病的医药品的用途
RU2007111685A (ru) Применение 9-оксоакридин-10-уксусной кислоты и/или ее соли в комбинации с антиэстрогеном и/или прогестином для лечения этрогензависимых опухолей, способ лечения и наборы